Company intelligence / Profile preview

Nutent Therapeutics

Florida, United Statesnutenttherapeutics.com ↗

Ownership: Private
Development stage: Commercial

Overview

Nutent Therapeutics develops and markets patented nutraceutical formulations—most notably GlucodOX, a guggul-based product that stimulates AMPK for metabolic health and longevity benefits. Their VOLT03 product offers pharmaceutical-grade curcumin with superior anti-inflammatory properties and bioavailability compared to standard turmeric extracts. The company differentiates itself by supporting its claims with clinical trials/data.

Therapeutic areas: Metabolic DisordersEndocrinologyImmunologyOther
Modalities: Small moleculeNutraceuticalPharmaceutical-grade supplement
Industry: Food & Nutrition

Drug pipeline

2 assets

GLUCODOX

Commercial

Indications: Metabolic disorders, Weight management

1 more asset in the full pipeline.

Request access →

Beyond the preview

Go deeper on Nutent Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nutent Therapeutics.

Explore the full profile